{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T03:45:08Z","timestamp":1768448708956,"version":"3.49.0"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T00:00:00Z","timestamp":1674172800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"DOD Peer Reviewed Medical Research Program","award":["W81XWH-19-1-0223"],"award-info":[{"award-number":["W81XWH-19-1-0223"]}]},{"DOI":"10.13039\/100007235","name":"Colorado State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007235","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Monkeypox virus has recently emerged from endemic foci in Africa and, since October 20, 2022, more than 73,000 human infections have been reported by the CDC from over 100 countries that historically have not reported monkeypox cases. The detection of virus in skin lesions, blood, semen, and saliva of infected patients with monkeypox infections raises the potential for disease transmission via routes that have not been previously documented, including by blood and plasma transfusions. Methods for protecting the blood supply against the threats of newly emerging disease agents exist and include Pathogen Reduction Technologies (PRT) which utilize photochemical treatment processes to inactivate pathogens in blood while preserving the integrity of plasma and cellular components. Such methods have been employed broadly for over 15 years, but effectiveness of these methods under routine use conditions against monkeypox virus has not been reported.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Study design and methods<\/jats:title>\n<jats:p>Monkeypox virus (strain USA_2003) was used to inoculate plasma and whole blood units that were then treated with riboflavin and UV light (Mirasol Pathogen Reduction Technology System, Terumo BCT, Lakewood, CO). The infectious titers of monkeypox virus in the samples before and after riboflavin + UV treatment were determined by plaque assay on Vero cells.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>The levels of spiked virus present in whole blood and plasma samples exceeded 10<jats:sup>3<\/jats:sup> infectious particles per dose, corresponding to greater than 10<jats:sup>5<\/jats:sup> DNA copies per mL. Treatment of whole blood and plasma units under standard operating procedures for the Mirasol PRT System resulted in complete inactivation of infectivity to the limits of detection. This is equivalent to a reduction of \u2265 2.86 +\/- 0.73 log<jats:sub>10<\/jats:sub> pfu\/mL of infectivity in whole blood and \u2265 3.47 +\/-0.19 log<jats:sub>10<\/jats:sub> pfu\/mL of infectivity in plasma under standard operating conditions for those products.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Based on this data and corresponding studies on infectivity in patients with monkeypox infections, use of Mirasol PRT would be expected to significantly reduce the risk of transfusion transmission of monkeypox.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0278862","type":"journal-article","created":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T18:26:25Z","timestamp":1674239185000},"page":"e0278862","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["Pathogen reduction of monkeypox virus in plasma and whole blood using riboflavin and UV light"],"prefix":"10.1371","volume":"18","author":[{"given":"Izabela K.","family":"Ragan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3131-3507","authenticated-orcid":true,"given":"Lindsay M.","family":"Hartson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth J.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard A.","family":"Bowen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5945-4571","authenticated-orcid":true,"given":"Raymond P.","family":"Goodrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2023,1,20]]},"reference":[{"issue":"3","key":"pone.0278862.ref001","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/trf.14455","article-title":"Metagenomics in pooled plasma, with identification of potential emerging infectious pathogens: METAGENOMICS IN POOLED PLASMA","volume":"58","author":"M Xu","year":"2018","journal-title":"Transfusion"},{"issue":"12","key":"pone.0278862.ref002","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.3201\/eid1112.050997","article-title":"Host Range and Emerging and Reemerging Pathogens","volume":"11","author":"MEJ Woolhouse","year":"2005","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"pone.0278862.ref003","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/voxs.12070","article-title":"Current perspectives in transfusion\u2010transmitted infectious diseases: emerging and re\u2010emerging infections","volume":"9","author":"SL Stramer","year":"2014","journal-title":"VOXS"},{"issue":"135","key":"pone.0278862.ref004","doi-asserted-by":"crossref","first-page":"20170555","DOI":"10.1098\/rsif.2017.0555","article-title":"Resource-driven encounters among consumers and implications for the spread of infectious disease","volume":"14","author":"RK Borchering","year":"2017","journal-title":"J R Soc Interface"},{"issue":"28","key":"pone.0278862.ref005","doi-asserted-by":"crossref","first-page":"7374","DOI":"10.1073\/pnas.1801383115","article-title":"Disease outbreak thresholds emerge from interactions between movement behavior, landscape structure, and epidemiology","volume":"115","author":"LA White","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"pone.0278862.ref006","doi-asserted-by":"crossref","first-page":"954","DOI":"10.3390\/ijerph16060954","article-title":"Modeling R0 for Pathogens with Environmental Transmission: Animal Movements, Pathogen Populations, and Local Infectious Zones","volume":"16","author":"JK Blackburn","year":"2019","journal-title":"IJERPH"},{"issue":"8","key":"pone.0278862.ref007","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1089\/vbz.2010.0114","article-title":"Human\u2013Bird Interactions in the United States Upland Gamebird Industry and the Potential for Zoonotic Disease Transmission","volume":"11","author":"KE Slota","year":"2011","journal-title":"Vector-Borne and Zoonotic Diseases"},{"key":"pone.0278862.ref008","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.virol.2015.10.020","article-title":"Experimental infection of peridomestic mammals with emergent H7N9 (A\/Anhui\/1\/2013) influenza A virus: Implications for biosecurity and wet markets","volume":"487","author":"JJ Root","year":"2016","journal-title":"Virology"},{"issue":"3","key":"pone.0278862.ref009","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/trf.14486","article-title":"Ignorance is not bliss: EDITORIAL","volume":"58","author":"RP Goodrich","year":"2018","journal-title":"Transfusion"},{"key":"pone.0278862.ref010","article-title":"Clinical and virological features of first human monkeypox cases in Germany","author":"S Noe","year":"2022","journal-title":"Infection"},{"issue":"1","key":"pone.0278862.ref011","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/tropicalmed1010008","article-title":"Human Monkeypox: Current State of Knowledge and Implications for the Future","volume":"1","author":"K Brown","year":"2016","journal-title":"TropicalMed"},{"issue":"4","key":"pone.0278862.ref012","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1053\/j.spid.2004.09.001","article-title":"Monkeypox: A review of the history and emergence in the Western hemisphere","volume":"15","author":"BL Ligon","year":"2004","journal-title":"Seminars in Pediatric Infectious Diseases"},{"issue":"8","key":"pone.0278862.ref013","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1056\/NEJMoa2207323","article-title":"Monkeypox Virus Infection in Humans across 16 Countries\u2014April\u2013June 2022","volume":"387","author":"JP Thornhill","year":"2022","journal-title":"N Engl J Med"},{"issue":"16","key":"pone.0278862.ref014","first-page":"5983","article-title":"Monkeypox: epidemiology, mode of transmission, clinical features, genetic clades and molecular properties","volume":"26","author":"S Kannan","year":"2022","journal-title":"European Review for Medical and Pharmacological Sciences"},{"issue":"11","key":"pone.0278862.ref015","article-title":"Monkeypox virus transmission to healthcare worker through needlestick injury","volume":"28","author":"L Bubach Carvalho","year":"2022","journal-title":"Emerging Infectious Diseases"},{"issue":"9","key":"pone.0278862.ref016","doi-asserted-by":"crossref","first-page":"638","DOI":"10.2471\/BLT.19.242347","article-title":"Modelling human-to-human transmission of monkeypox","volume":"98","author":"R Grant","year":"2020","journal-title":"Bull World Health Organ"},{"issue":"4","key":"pone.0278862.ref017","doi-asserted-by":"crossref","first-page":"782","DOI":"10.3201\/eid2604.191164","article-title":"Human-to-Human Transmission of Monkeypox Virus, United Kingdom, October 2018","volume":"26","author":"A Vaughan","year":"2020","journal-title":"Emerg Infect Dis"},{"issue":"22","key":"pone.0278862.ref018","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2022.27.22.2200422","article-title":"Community transmission of monkeypox in the United Kingdom, April to May 2022","volume":"27","author":"R Vivancos","year":"2022","journal-title":"Eurosurveillance"},{"key":"pone.0278862.ref019","doi-asserted-by":"crossref","first-page":"100593","DOI":"10.1016\/j.blre.2019.100593","article-title":"Review of current transfusion therapy and blood banking practices","volume":"38","author":"EK Storch","year":"2019","journal-title":"Blood Reviews"},{"issue":"5","key":"pone.0278862.ref020","doi-asserted-by":"crossref","first-page":"103195","DOI":"10.1016\/j.transci.2021.103195","article-title":"Remodelling whole blood processing through automation and pathogen reduction technology at the Luxembourg Red Cross","volume":"60","author":"N Malvaux","year":"2021","journal-title":"Transfusion and Apheresis Science"},{"issue":"5","key":"pone.0278862.ref021","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/bjh.16093","article-title":"The long and winding road to pathogen reduction of platelets, red blood cells and whole blood","volume":"186","author":"P. Rebulla","year":"2019","journal-title":"Br J Haematol"},{"issue":"10029","key":"pone.0278862.ref022","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/S0140-6736(16)00581-X","article-title":"Effect of Plasmodium inactivation in whole blood on the incidence of blood transfusion-transmitted malaria in endemic regions: the African Investigation of the Mirasol System (AIMS) randomised controlled trial","volume":"387","author":"JP Allain","year":"2016","journal-title":"The Lancet"},{"issue":"93","key":"pone.0278862.ref023","first-page":"52065","article-title":"Viral Concentration Determination Through Plaque Assays: Using Traditional and Novel Overlay Systems","author":"A Baer","year":"2014","journal-title":"JoVE"},{"issue":"2","key":"pone.0278862.ref024","doi-asserted-by":"crossref","first-page":"e0010141","DOI":"10.1371\/journal.pntd.0010141","article-title":"The changing epidemiology of human monkeypox\u2014A potential threat? A systematic review","volume":"16","author":"EM Bunge","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"issue":"28","key":"pone.0278862.ref025","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2022.27.28.2200503","article-title":"Frequent detection of monkeypox virus DNA in saliva, semen, and other clinical samples from 12 patients, Barcelona, Spain, May to June 2022","volume":"27","author":"A Peir\u00f3-Mestres","journal-title":"Eurosurveillance"},{"issue":"35","key":"pone.0278862.ref026","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2022.27.35.2200636","article-title":"Monkeypox DNA levels correlate with virus infectivity in clinical samples, Israel, 2022","volume":"27","author":"N Paran","year":"2022","journal-title":"Eurosurveillance"},{"issue":"5","key":"pone.0278862.ref027","doi-asserted-by":"crossref","first-page":"e0233947","DOI":"10.1371\/journal.pone.0233947","article-title":"Pathogen reduction of SARS-CoV-2 virus in plasma and whole blood using riboflavin and UV light","volume":"15","author":"I Ragan","year":"2020","journal-title":"PLoS ONE"},{"issue":"7","key":"pone.0278862.ref028","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1111\/trf.13030","article-title":"Inactivation of viruses in platelet and plasma products using a riboflavin-and-UV-based photochemical treatment: INACTIVATION OF VIRUSES USING RIBOFLAVIN AND UV","volume":"55","author":"SD Keil","year":"2015","journal-title":"Transfusion"},{"issue":"2","key":"pone.0278862.ref029","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1537-2995.2012.03717.x","article-title":"Photochemical inactivation of chikungunya virus in plasma and platelets using the Mirasol pathogen reduction technology system: MIRASOL INACTIVATION OF CHIKUNGUNYA VIRUS","volume":"53","author":"DL Vanlandingham","year":"2013","journal-title":"Transfusion"},{"issue":"3","key":"pone.0278862.ref030","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/vox.12414","article-title":"Riboflavin and ultraviolet light: impact on dengue virus infectivity","volume":"111","author":"HM Faddy","year":"2016","journal-title":"Vox Sang"},{"issue":"3","key":"pone.0278862.ref031","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1182\/blood.V59.3.482.482","article-title":"Interaction between vaccinia virus and human blood platelets","volume":"59","author":"T Bik","year":"1982","journal-title":"Blood"},{"key":"pone.0278862.ref032","article-title":"Low levels of monkeypox virus neutralizing antibodies after MVA-BN vaccination in healthy individuals","author":"LM Zaeck","year":"2022","journal-title":"Infectious Diseases (except HIV\/AIDS)"},{"key":"pone.0278862.ref033","article-title":"Susceptibility to monkeypox virus infection: seroprevalence of orthopoxvirus in 4 population samples; France, Bolivia, Laos and Mali","author":"L Luciani","year":"2022","journal-title":"Infectious Diseases (except HIV\/AIDS)"},{"issue":"6612","key":"pone.0278862.ref034","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1126\/science.ade8470","article-title":"Moving Target: The global monkeypox outbreak is givng the virus an unprecedented opportunity to adapt to humans. will it change for the worse?","volume":"377","author":"Kai Kupferschmidt","year":"2022","journal-title":"Science"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0278862","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T18:26:50Z","timestamp":1674239210000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0278862"}},"subtitle":[],"editor":[{"given":"Luisa","family":"Gregori","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2023,1,20]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0278862","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,20]]}}}